Cytokine signalling by gp130 regulates gastric mucosal healing after ulceration and, indirectly, antral tumour progression

Journal of Pathology

Volumn 217, Issue 4, 2009, Pages 552-562

  Judd, Louise M ^a,b   Ulaganathan, Meera ^a,b   Howlett, Meegan ^a,b   Giraud, Andrew S ^a,b  

^a UNIVERSITY OF MELBOURNE   (Australia)

^b ROYAL CHILDREN'S HOSPITAL   (Australia)

Author keywords

Extracellular matrix; IL 11; Reg; STAT3; Stomach; Tumour; Ulceration

Indexed keywords

ACETIC ACID; GLYCOPROTEIN GP 130; INTERLEUKIN 11; INTERLEUKIN 11 RECEPTOR ALPHA; INTERLEUKIN 6; MESSENGER RNA; STAT3 PROTEIN;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CARCINOGENESIS; CELL PROLIFERATION; CONTROLLED STUDY; DISEASE SEVERITY; EPITHELIUM HYPERPLASIA; GENE TARGETING; HEMOSTASIS; MOUSE; NECROSIS; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SEROSA; SIGNAL TRANSDUCTION; STOMACH ANTRUM; STOMACH EPITHELIUM; STOMACH FUNDUS; STOMACH MUCOSA; STOMACH TUMOR; STOMACH ULCER; TUMOR GROWTH; ULCER HEALING; WOUND HEALING; ANIMAL; C57BL MOUSE; CHEMICALLY INDUCED DISORDER; COMPARATIVE STUDY; DISEASE COURSE; FIBROSIS; GENETICS; IMMUNOBLOTTING; IMMUNOHISTOCHEMISTRY; IMMUNOLOGY; METABOLISM; MOUSE MUTANT; PATHOLOGY; PHYSIOLOGY;

ACETIC ACID; ANIMALS; CELL PROLIFERATION; CYTOKINE RECEPTOR GP130; DISEASE PROGRESSION; FIBROSIS; GASTRIC MUCOSA; IMMUNOBLOTTING; IMMUNOHISTOCHEMISTRY; INTERLEUKIN-11; INTERLEUKIN-6; MICE; MICE, INBRED C57BL; MICE, KNOCKOUT; MODELS, ANIMAL; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; SIGNAL TRANSDUCTION; STOMACH NEOPLASMS; STOMACH ULCER; WOUND HEALING;

EID: 62849090557     PISSN: 00223417     EISSN: 10969896     Source Type: Journal    
DOI: 10.1002/path.2479     Document Type: Article

References (44)

1. Furukawa K, Takahashi T, Arai F, Matsushima K, Asakura H. Enhanced mucosal expression of interleukin-6 mRNA but not of interleukin-8 mRNA at the margin of gastric ulcer in Helicobacter pylori-positive gastritis. J Gastroenterol 1998;33(5):625-633.
2. Pathak SK, Basu S, Bhattacharyya A, Pathak S, Banerjee A, Basu J, et al. TLR4-dependent NF-κB activation and mitogen- and stress-activated protein kinase 1-triggered phosphorylation events are central to Helicobacter pylori peptidyl prolyl cis-, trans-isomerase (HP0175)-mediated induction of IL-6 release from macrophages. J Immunol 2006;177(11):7950-7958.
3. Nishida T, Tsuji S, Kimura A, Tsujii M, Ishii S, Yoshio T, et al. Endothelin-1, an ulcer inducer, promotes gastric ulcer healing via mobilizing gastric myofibroblasts and stimulates production of stroma-derived factors. Am J Physiol Gastrointest Liver Physiol 2006;290(5):G1041-1050.
4. Pradeepkumar Singh L, Kundu P, Ganguly K, Mishra A, Swarnakar S. Novel role of famotidine in down-regulation of matrix metalloproteinase-9 during protection of ethanol-induced acute gastric ulcer. Free Radio Biol Med 2007;43(2):289-299.
5. Wen CY, Ito M, Matsuu M, Fukuda E, Shichijo K, Nakashima M, et al. Mechanism of the antiulcerogenic effect of IL-11 on acetic acid-induced gastric ulcer in rats. Life Sci 2002;70(25):2997-3005.
6. Wen CY, Ito M, Wang H, Chen LD, Xu ZM, Matsuu M, et al. IL-11 up-regulates Tie-2 expression during the healing of gastric ulcers in rats. World J Gastroenterol 2003;9(4):788-790.
7. Kopf M, Baumann H, Freer G, Freudenberg M, Lamers M, Kishimoto T, et al. Impaired immune and acute-phase responses in interleukin-6-deficient mice. Nature 1994;368(6469):339-342.
8. Nandurkar HH, Robb L, Tarlinton D, Barnett L, Kontgen F, Begley CG. Adult mice with targeted mutation of the interleukin-11 receptor (IL11Ra) display normal hematopoiesis. Blood 1997;90(6):2148-2159.
9. Balkwill F, Mantovani A. Inflammation and cancer: back to Virchow? Lance 2001;357(9255):539-545.
10. Marx J. Cancer research. Inflammation and cancer: the link grows stronger. Science 2004;306(5698):966-968.
11. Coussens LM, Werb Z. Inflammation and cancer. Nature 2002;420(6917):860-867.
12. Balkwill F, Charles KA, Mantovani A. Smoldering and polarized inflammation in the initiation and promotion of malignant disease. Cancer Cell 2005;7(3):211-217.
13. Houghton J, Wang TC. Helicobacter pylori and gastric cancer: a new paradigm for inflammation-associated epithelial cancers. Gastroenterology 2005;128(6): 1567-1578.
14. Crowe SE. Helicobacter infection, chronic inflammation, and the development of malignancy. Curr Opin Gastroenterol 2005;21(1):32- 38.
15. Peek RM Jr, Crabtree JE. Helicobacter infection and gastric neoplasia. J Pathol 2006;208(2):233-248.
16. Go MF. Review article: natural history and epidemiology of Helicobacter pylori infection. Aliment Pharmacol Ther 2002;16(suppl 1):3-15.
17. Jackson CB, Judd LM, Menheniott TR, Kronborg I, Dow C, Yeomans ND, et al. Augmented gp130-mediated cytokine sig nalling accompanies human gastric cancer progression. J Pathol 2007;213(2):140-151.
18. Choi JH, Ahn MJ, Park CK, Han HX, Kwon SJ, Lee YY, et al. Phospho-Stat3 expression and correlation with VEGF, p53, and Bcl-2 in gastric carcinoma using tissue microarray. Acta Pathol Microbiol Immunol Scand 2006;114(9):619-625.
19. Yakata Y, Nakayama T, Yoshizaki A, Kusaba T, Inoue K, Sekine I. Expression of p-STAT3 in human gastric carcinoma: signifi cant correlation in tumour invasion and prognosis. Int J Oncol 2007;30(2):437-442.
20. Kanda N, Seno H, Konda Y, Marusawa H, Kanai M, Nakajima T, et al. STAT3 is constitutively activated and supports cell survival in association with survivin expression in gastric cancer cells. Oncogene 2004;23(28):4921-4929.
21. Tebbutt NC, Giraud AS, Inglese M, Jenkins B, Waring P, Clay FJ, et al. Reciprocal regulation of gastrointestinal homeostasis by SHP2 and STAT- mediated trefoil gene activation in gp130 mutant mice. Nat Med 2002;8(10):1089-1097.
22. Judd LM, Alderman BM, Howlett M, Shulkes A, Dow C, Moverley J, et al. Gastric cancer development in mice lacking the SHP2 binding site on the IL-6 family co-receptor gp130. Gastroenterol ogy 2004;126(1):196- 207.
23. Howlett M, Judd LM, Jenkins B, La Gruta NL, Grail D, Ernst M, et al. Differential regulation of gastric tumor growth by cytokines that signal exclusively through the coreceptor gp130. Gastroenterology 2005;129(3):1005-1018.
24. Judd LM, Bredin K, Kalantzis A, Jenkins BJ, Ernst M, Giraud AS. STAT3 activation regulates growth, inflammation and vasculariza tion in a mouse model of gastric tumorigenesis. Gastroenterology 2006;131(4):1073-1085.
25. Jenkins BJ, Grail D, Nheu T, Najdovska M, Wang B, Waring P, et al. Hyperactivation of Stat3 in gp130 mutant mice promotes gastric hyperproliferation and desensitizes TGF-β signaling. Nat Med 2005;11(8):845-852.
26. Kinoshita Y, Ishihara S, Kadowaki Y, Fukui H, Chiba T. Reg protein is a unique growth factor of gastric mucosal cells. J Gastroenterol 2004;39(6):507-513.
27. Cash HL, Whitham CV, Behrendt CL, Hooper LV. Symbiotic bacteria direct expression of an intestinal bactericidal lectin. Science 2006;313(5790):1126-1130.
28. Shahin M, Konturek JW, Pohle T, Schuppan D, Herbst H, Dom schke W. Remodeling of extracellular matrix in gastric ulceration. Microsc Res Technol 2001;53(6):396-408.
29. Baragi VM, Qiu L, Gunja-Smith Z, Woessner JF Jr, Lesch CA, Guglietta A. Role of metalloproteinases in the development and healing of acetic acid-induced gastric ulcer in rats. Scand J Gastroenterol 1997;32(5):419-426.
30. Swarnakar S, Ganguly K, Kundu P, Banerjee A, Maity P, Sharma AV. Curcumin regulates expression and activity of matrix metalloproteinases 9 and 2 during prevention and healing of indomethacin-induced gastric ulcer. J Biol Chem 2005;280(10):9409-9415.
31. Ganguly K, Kundu P, Banerjee A, Reiter RJ, Swarnakar S. Hydro gen peroxide-mediated down-regulation of matrix metalloprotease-2 in indomethacin-induced acute gastric ulceration is blocked by melatonin and other antioxidants. Free Radic Biol Med 2006;41(6):911-925.
32. Cho JH. The genetics and immunopathogenesis of inflammatory bowel disease. Nat Rev Immunol 2008;8(6):458-466.
33. Orazi A, Du X, Yang Z, Kashai M, Williams DA. Interleukin-11 prevents apoptosis and accelerates recovery of small intestinal mucosa in mice treated with combined chemotherapy and radiation. Lab Invest 1996;75(1): 33-42.
34. Fukui T, Nishio A, Okazaki K, Uza N, Ueno S, Kido M, et al. Gastric mucosal hyperplasia via upregulation of gastrin induced by persistent activation of gastric innate immunity in major histocompatibility complex class II deficient mice. Gut 2006;55(5):607-615.
35. Ose T, Kadowaki Y, Fukuhara H, Kazumori H, Ishihara S, Udagawa J, et al. Reg I-knockout mice reveal its role in regulation of cell growth that is required in generation and maintenance of the villous structure of small intestine. Oncogene 2007;26(3):349-359.
36. Kazumori H, Ishihara S, Hoshino E, Kawashima K, Moriyama N, Suetsugu H, et al. Neutrophil chemoattractant 2β regulates expression of the Reg gene in injured gastric mucosa in rats. Gastroenterology 2000;119(6):1610-1622.
37. Asahara M, Mushiake S, Shimada S, Fukui H, Kinoshita Y, Kawanami C, et al. Reg gene expression is increased in rat gastric enterochromaffin-like cells following water immersion stress. Gastroenterology 1996;111(1):45-55.
38. Frank TV, Judd LM, Nguyen NV, Samuelson LC, Loveland KL, Giraud AS, et al. Growth factors associated with gastric mucosal hypertrophy in autoimmune gastritis. Am J Physiol Gastrointest Liver Physiol 2004;287(4):G910-918.
39. Unno M, Nata K, Noguchi N, Narushima Y, Akiyama T, Ikeda T, et al. Production and characterization of Reg knockout mice: reduced proliferation of pancreatic β cells in Reg knockout mice. Diabetes 2002;51(suppl 3):S478-483.
40. Miyaoka Y, Kadowaki Y, Ishihara S, Ose T, Fukuhara H, Kazu mori H, et al. Transgenic overexpression of Reg protein caused gastric cell proliferation and differentiation along parietal cell and chief cell lineages. Oncogene 2004;23(20):3572-3579.
41. Calabro A, Grappone C, Pellegrini G, Evangelista S, Tramon tana M, Schuppan D, et al. Spatial and temporal pattern of expres sion of interstitial collagenase, stromelysin/transin, gelatinase A, and TIMP-1 during experimental gastric ulcer healing. Digestion 2004;70(2):127-138.
42. Oosterling SJ, van der Bij GJ, Meijer GA, Tuk CW, van Garderen E, van Rooijen N, et al. Macrophages direct tumour histology and clinical outcome in a colon cancer model. J Pathol 2005;207(2):147-155.
43. Chen JJ, Lin YC, Yao PL, Yuan A, Chen HY, Shun CT, et al. Tumor-associated macrophages: the double-edged sword in cancer progression. J Clin Oncol 2005;23(5):953-964.
44. Ishigami S, Natsugoe S, Tokuda K, Nakajo A, Okumura H, Matsumoto M, et al. Tumor-associated macrophage (TAM) infiltration in gastric cancer. Anticancer Res 2003;23(5A):4079-4083.